跳至主要内容
临床试验/ISRCTN95870846
ISRCTN95870846已完成未知

ymphoedema prevention in breast cancer: a simple blind, randomised, prospective clinical trial of the efficacy of early physical therapy

The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)0 个研究点目标入组 120 人开始时间: 2008年10月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Consecutive women diagnosed with breast cancer and undergoing unilateral surgery with axillary lymph-node dissection at the Principe de Asturias Hospital in Alcala de Henares, Madrid (Spain)
  • 2. Aged 18 to 70 years old

排除标准

  • 1. Without axillary lymph-node dissection or with bilateral breast cancer (BC)
  • 2. Systemic disease
  • 3. Locoregional recurrence
  • 4. Any contraindication to physical therapy

研究者

发起方
The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)

相似试验

进行中(未招募)
1 期
Prevention of breast cancer-related lymphedema with tacrolimusymphedemaMedDRA version: 20.0Level: LLTClassification code 10025233Term: LymphedemaSystem Organ Class: 100000004866
EUCTR2018-003416-50-DKOdense University Hospital40
已完成
不适用
Treatment of breast cancer-associated lymphedema. A randomized study of the (cost-)effectiveness of manual lymphatic drainage and/or intermittent pneumatic compressioLymphedema100062911004079510025231
NL-OMON30736Academisch Ziekenhuis Maastricht207
Unknown
1 期
Prevention of Breast Cancer-related Lymphedma With TacrolimusLymphedema
NCT04390685Odense University Hospital60
进行中(未招募)
不适用
Preoperative treatment of breast cancer with a combination of epirubicin, docetaxel and bevacizumab. A translational trial on molecular markers and functional imaging to predict response early - PROMIXPatients diagnosed with breast cancer who are candidates for preoperative (neoadjuvant) chemotherapy due to localized primary breast cancer including inflammatory breast cancer suitable for primary medical treatment and/or regional lymph node metastases including ipsilateral supraclavicular nodes with breast cancer diagnosis confirmed by histological examination.MedDRA version: 9.1Level: LLTClassification code 10006200Term: Breast cancer stage IIMedDRA version: 9.1Level: LLTClassification code 10006201Term: Breast cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10021974Term: Inflammatory breast cancer
EUCTR2007-005858-23-SEPROMIX Trial Group200
招募中
不适用
Prevention of breast edema with a compression bra (CoBra)Breast cancerRadiotherapyplastic surgeryBorstkankerRadiotherapiePlastische Heelkunde
NL-OMON23066niversity of Antwerpin corporation with the Antwerp University Hospital76